PPARG and breast cancer: Elstneret al. showed that PPARγ ligands, troglitazone, 15dPGJ2, and indomethacin, caused inhibitionof proliferation in several human breast cancer cell lines, such as MCF7,MDA-MB-231, BT474, and T47D [162].